Recall archive / FDA company announcement

Umary: UMARY Hyaluronic Acid tablets — FDA announcement Nov 21, 2024

Published notice; closure not supplied

A company announcement posted by FDA. The listing date can differ from the original announcement date. The absence of a termination marker does not prove the recall is currently ongoing.

Source date Nov 21, 2024. Retrieved Oct 1, 2026. Last updated Oct 1, 2026.

Archive changed Oct 1, 2026. USDA FSIS records are unavailable; check FSIS directly. Source coverage and dates.

What the record says

Product: UMARY Hyaluronic Acid tablets
Reason: The product contains undeclared diclofenac and omeprazole
Classification: Not supplied
Recalling firm: MXBBB
Quantity: Not supplied
Agency-reported status: Company recall announcement
Source record identifier: 3f9af5d2aac7371f

Open the official record

Lot and product identifiers

Label field	Details supplied by the agency
Lot, code or applicability	MXBBB is voluntarily recalling 1 lot of UMARY ACID HYALURONIC, 30 CAPLETS 850 MG to the consumer level. The products have been found to have omeprazole and diclofenac. FDA did a laboratory analysis that confirmed that Umary contains diclofenac and omeprazole.; The product is used as dietary supplement and is packaged in a plastic container. The affected UMARY Acid hyaluronic. UPC:7502265120323 30 caplets of 850mg include the following Lot number: 24183 and the expiration date: 07/01/28. 321 units were distributed.

Label field

Details supplied by the agency

Lot, code or applicability

MXBBB is voluntarily recalling 1 lot of UMARY ACID HYALURONIC, 30 CAPLETS 850 MG to the consumer level. The products have been found to have omeprazole and diclofenac. FDA did a laboratory analysis that confirmed that Umary contains diclofenac and omeprazole.; The product is used as dietary supplement and is packaged in a plastic container. The affected UMARY Acid hyaluronic. UPC:7502265120323 30 caplets of 850mg include the following Lot number: 24183 and the expiration date: 07/01/28. 321 units were distributed.

Match all identifying details in the current notice. A brand name alone is not enough.

Distribution

The product is used as dietary supplement and is packaged in a plastic container. The affected UMARY Acid hyaluronic. UPC:7502265120323 30 caplets of 850mg include the following Lot number: 24183 and the expiration date: 07/01/28. 321 units were distributed.

No US distribution state could be established from this record. Check the official notice.

Dates in the source

Fda listing date: Nov 21, 2024
Company announcement date: Nov 21, 2024

FDA company pages use the listing date; enforcement records use initiation dates; CPSC uses recall date; NHTSA uses report-received date. These dates are not interchangeable.